A sparrow device on a blue and teal background.

The Breakthrough Is Here: Billion-Dollar Opportunity

Sparrow has solved one of the hardest problems in diagnostics with the first $100 sample-to-result PCR analyzer. Now we're seeking partners to take it to market.

Partner With Us

Path to Market

01
Done

Core technology, after 20 years of R&D

02
Next

Test menu development, regulatory clearances, and manufacturing

03
Then

Commercialization

Hands holding a Sparrow device over a blue sky background.
A sparrow device on a blue and teal background/

New Consumer Market

Lab-Based PCR

$15 Billion

PCR at Home

10× Potential
Recuring Revenues
Sparrow’s Test Cartridges Enable
90% Margins
Hands holding a Sparrow device over a blue sky background.
Potential Applications

Infectious Diseases

Chlamydia & Gonorrhea, Influenza, Strep throat, Tuberculosis

Cancer

Human Papilloma Virus (HPV)

Food Safety

E. coli, Listeria, Salmonella

Water Safety

E. coli, Legionella, Pseudomonas

Veterinary

October 27, 2026
4 Minutes
Sparrow Bio

Sparrow Bio announces first $100 personal DNA analyzer

Company seeks strategic partners for test menu development and regulatory clearances.

Read more
A hand opening the lid of a Sparrow prototype.
Seeking strategic partners
Thank you for your interest in partnering with Sparrow. We'll be in touch as soon as we can!
Oops! Something went wrong while submitting the form.
Sparrow Bio's logo
First $100 personal DNA analyzer
InstagramLinkedIn
Company
ProductPArtnerships
About
NewsAboutContact
© 2026 Sparrow Bio Inc. All rights Reserved
The Sparrow analyzer is for research use only. Not for use in diagnostic procedures.
PrivacyLegal